Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses중증 급성 호흡기 증후군 코로나바이러스 2의 은밀한 사례: 뎅기열 및 치쿤구니야 바이러스 풍토병 지역의 모호하지만 존재하는 위험Research Article Published on 2021-01-062022-09-10 Journal: PLoS ONE [Category] 진단, 치료기술, [키워드] acute infection acute infections antibody Brazil Chikungunya Clinical features clinical symptom Clinical symptoms collected conducted contributed coronavirus covert COVID-19 COVID-19 diagnosis Dengue dengue virus Diagnosis diagnosis of SARS-CoV-2 Endemic expected feature finding IgG immunoassay Immunoglobulin Immunoglobulin G infections knowledge Microparticle outbreak Patient patients positive Presence Prevalence prevalent Region regions respiratory robust Sample size SAR-CoV-2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 nucleoprotein serum sample serum samples tested Viral viral infection virus [DOI] 10.1371/journal.pone.0244937 PMC 바로가기 [Article Type] Research Article
Eastern Cape Healthcare Workers Acquisition of SARS-CoV-2 (ECHAS): Cross-Sectional (Nested Cohort) Study Protocol이스턴 케이프 의료 종사자 SARS-CoV-2(ECHAS) 획득: 횡단면(중첩 코호트) 연구 프로토콜Protocol Published on 2021-01-052022-09-10 Journal: International Journal of Environmental Research an [Category] 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 addition African Antenatal antibody antibody assay antibody levels Cape Chain Reaction Clinical characteristics Cluster CMIA Cohort cohort study Community community infection conducted Coronavirus-2 country COVID-19-related death cross-sectional cross-sectional study cumulative decay Department Eastern Cape Effectiveness Fatality rate finding HCW HCWs Health health facilities healthcare worker Healthcare workers highlight humoral immune response identify IgG antibodies IgG antibody immunoassay increased risk independent risk factor independent risk factors Infection Infection prevention infection rate logistic regression models longitudinal change longitudinal changes measure Microparticle offer pandemic participant polymerase chain polymerase chain reaction positive Prevention and control PROTECT Protein qualitative detection questionnaire recruited Regression model Reinfection respiratory reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid SARS-CoV-2 RT-PCR SARS-CoV-2 serology SARS-CoV-2 seroprevalence second wave selected serology South South Africa tested the SARS-CoV-2 virulent women worker [DOI] 10.3390/ijerph18010323 PMC 바로가기 [Article Type] Protocol
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India – A cross-sectional study인도 북부 스리나가르 지구에서 SARS-CoV-2 특이적 IgG 항체의 혈청 유병률 – 단면 연구Research Article Published on 2020-11-112022-08-13 Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS, SARS, [키워드] 95% CI adjusted age Background Prevalence cross-sectional disease District higher odd higher odds hospital IgG antibodies IgG antibody India Infection Influenza information Measures median Microparticle participated people with symptom proportion provide quarantine Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections selected serologic test Seroprevalence significantly specific IgG antibodies specific IgG antibody susceptible Symptom tested the District with COVID-19 [DOI] 10.1371/journal.pone.0239303 PMC 바로가기 [Article Type] Research Article
Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational StudyConference abstract Published on 2020-11-042022-10-05 Journal: Blood [Category] 바이오마커, [키워드] Activation acute respiratory distress acute respiratory syndrome Algorithm Antithrombotic AP-HP ARDS Biomarker Blood coagulation calculated cause cellular change characterized clinically clotting factor Cluster Coagulation cohort study complications consecutive patient Control control group controls coronavirus coronavirus disease COVID-19 D-dimer decrease disease download effect of treatment endothelial Endothelial cell Endothelial dysfunction enrolled evaluate evaluated excessive inflammation expressing fibrinogen FVIII healthy individual Heparanase Hospitalized hypercoagulability ICU ICU admission ICU patient IL-6 IL-6 level increase indicate indicated inflammatory reaction Inhaled inhibitor intensive care unit intrinsic life-threatening LMWH management mandatory Microparticle moderate modify molecular weight monomer MRI Multisystem organ failure outcome Paris pathway Patient patients patients hospitalized patients with COVID-19 peak platelet activation Pneumonia Prospective Prospective Study Protein protein S ranged Ratio Respiratory failure Result SARS-CoV-2 SARS-COV-2 infection severe COVID-19 shown significant decrease significantly STABLE syndrome table TFPI the mean the patient thrombin Thromboprophylaxis university von Willebrand factor were assessed with COVID-19 [DOI] 10.1182/blood-2020-140275 [Article Type] Conference abstract
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film FreezingArticle Published on 2020-10-222022-10-28 Journal: Pharmaceutics [Category] COVID-19, [키워드] absorbed affected aggregate antiviral therapy approval brittle matrix powder circulation Course COVID-19 demonstrated development Dry dry powder for inhalation Dry powder inhaler effective Emergency use exhibit exhibited film freezing greater GS-441524 hydrolyzed in vitro activity in vivo inhalation leucine low-density lung Lungs median Microparticle morbidity and mortality patients with COVID-19 pharmacokinetic powder reduce Remdesivir SARS-CoV-2 the disease Thin thin film freezing treat [DOI] 10.3390/pharmaceutics12111002 PMC 바로가기 [Article Type] Article
A New Vaccine Delivery Vehicle and Adjuvant Candidate: Bordetella pertussis Inactivated Whole Cells Entrapped in Alginate Microspheresarticle Published on 2017-12-312024-09-01 Journal: Current Pharmaceutical Design [Category] 백일해, [키워드] Bacteria Bordetella pertussis immunogenicity Microparticle potency whole cell vaccine [Article Type] article
Red blood cells release microparticles containing human argonaute 2 and miRNAs to target genes of Plasmodium falciparum적혈구는 플라스모디움 팔시파룸의 표적 유전자에 인간 아르고나우트 2와 miRNA를 포함한 미세입자를 방출한다.Original Article Published on 2017-08-232024-08-12 Journal: Emerging Microbes & Infections [Category] 말라리아, [키워드] human argonaute 2 malaria Microparticle miRNA Plasmodium falciparum [DOI] 10.1038/emi.2017.63 PMC 바로가기 [Article Type] Original Article
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusReview Published on 2016-12-022023-08-29 Journal: Vaccines [Category] E형 간염, [키워드] Microparticle nanoparticle RSV Vaccine VLPs [DOI] 10.3390/vaccines4040045 PMC 바로가기 [Article Type] Review